Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; dextrin; lactose monohydrate; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: dextrin; maize starch; magnesium stearate; lactose monohydrate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.05 mg - tablet, uncoated - excipient ingredients: dextrin; maize starch; lactose monohydrate; magnesium stearate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: dextrin; magnesium stearate; lactose monohydrate; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: dextrin; lactose monohydrate; maize starch; magnesium stearate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.05 mg - tablet, uncoated - excipient ingredients: dextrin; magnesium stearate; lactose monohydrate; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - levothyroxine sodium anhydrous - oral solution - 5microgram/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - levothyroxine sodium anhydrous - oral solution - 10microgram/1ml

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; pregelatinised starch; microcrystalline cellulose; allura red ac aluminium lake; indigo carmine aluminium lake - levothyroxine sodium is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sodium is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet - excipient ingredients: magnesium stearate; hyprolose; pregelatinised starch; microcrystalline cellulose; sunset yellow fcf aluminium lake; quinoline yellow aluminium lake - levothyroxine sodium is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sodium is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.